Breadcrumb Home Search ClinicalTrials.gov ID: For more information on this trial, visit clinicaltrials.gov . Summary Eligibility Contact Summary Eligibility Criteria Min Age N/A Max Age N/A Download Date Principal Investigator N/A Primary Contact …

Breadcrumb Home Search ClinicalTrials.gov ID: For more information on this trial, visit clinicaltrials.gov . Summary Eligibility Contact Summary Eligibility Criteria Min Age N/A Max Age N/A Download Date Principal Investigator N/A Primary Contact …

Breadcrumb Home Search ClinicalTrials.gov ID: For more information on this trial, visit clinicaltrials.gov . Summary Eligibility Contact Summary Eligibility Criteria Min Age N/A Max Age N/A Download Date Principal Investigator N/A Primary Contact …

Breadcrumb Home Search ClinicalTrials.gov ID: For more information on this trial, visit clinicaltrials.gov . Summary Eligibility Contact Summary Eligibility Criteria Min Age N/A Max Age N/A Download Date Principal Investigator N/A Primary Contact …

Breadcrumb Home Search ClinicalTrials.gov ID: For more information on this trial, visit clinicaltrials.gov . Summary Eligibility Contact Summary Eligibility Criteria Min Age N/A Max Age N/A Download Date Principal Investigator Alexander Rotenberg This …

Breadcrumb Home Search ClinicalTrials.gov ID: For more information on this trial, visit clinicaltrials.gov . Summary Eligibility Contact Summary Eligibility Criteria Min Age N/A Max Age N/A Download Date Principal Investigator N/A Primary Contact …

Breadcrumb Home Search ClinicalTrials.gov ID: For more information on this trial, visit clinicaltrials.gov . Summary Eligibility Contact Summary Eligibility Criteria Min Age N/A Max Age N/A Download Date Principal Investigator N/A Primary Contact …

Breadcrumb Home Search ClinicalTrials.gov ID: For more information on this trial, visit clinicaltrials.gov . Summary Eligibility Contact Summary Eligibility Criteria Min Age N/A Max Age N/A Download Date Principal Investigator N/A Primary Contact …

NCT05156047 NCT05156047 A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic HypersomniaThe primary objective of this study is to evaluate the safety and efficacy of pitolisant compared with placebo …

NCT05132322 NCT05132322 Eliminating Monitor Overuse Trial (EMO Trial)The purpose of this study is to identify the optimal deimplementation strategies for an overused practice: continuous pulse oximetry monitoring of children hospitalized with …